136 related articles for article (PubMed ID: 30773850)
21. PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation.
Qing H; Gong W; Che Y; Wang X; Peng L; Liang Y; Wang W; Deng Q; Zhang H; Jiang B
Tumour Biol; 2012 Aug; 33(4):985-94. PubMed ID: 22252525
[TBL] [Abstract][Full Text] [Related]
22. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
23. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.
Goc A; Al-Azayzih A; Abdalla M; Al-Husein B; Kavuri S; Lee J; Moses K; Somanath PR
J Biol Chem; 2013 Feb; 288(5):3025-35. PubMed ID: 23258534
[TBL] [Abstract][Full Text] [Related]
24. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition.
Villamar Cruz O; Prudnikova TY; Araiza-Olivera D; Perez-Plasencia C; Johnson N; Bernhardy AJ; Slifker M; Renner C; Chernoff J; Arias-Romero LE
Oncotarget; 2016 Nov; 7(47):76590-76603. PubMed ID: 27740936
[TBL] [Abstract][Full Text] [Related]
25. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
26. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
27. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
28. P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.
Yao D; Li C; Rajoka MSR; He Z; Huang J; Wang J; Zhang J
Theranostics; 2020; 10(21):9741-9766. PubMed ID: 32863957
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
30. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis.
Wang G; Song Y; Liu T; Wang C; Zhang Q; Liu F; Cai X; Miao Z; Xu H; Xu H; Cao L; Li F
Oncotarget; 2015; 6(12):9877-86. PubMed ID: 25888627
[TBL] [Abstract][Full Text] [Related]
31. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
[TBL] [Abstract][Full Text] [Related]
32. PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion.
Wang G; Zhang Q; Song Y; Wang X; Guo Q; Zhang J; Li J; Han Y; Miao Z; Li F
Cell Death Dis; 2015 Mar; 6(3):e1682. PubMed ID: 25766321
[TBL] [Abstract][Full Text] [Related]
33. IPA-3 inhibits the growth of liver cancer cells by suppressing PAK1 and NF-κB activation.
Wong LL; Lam IP; Wong TY; Lai WL; Liu HF; Yeung LL; Ching YP
PLoS One; 2013; 8(7):e68843. PubMed ID: 23894351
[TBL] [Abstract][Full Text] [Related]
34. W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
Xia Y; Weng B; Wang Z; Kang Y; Shi L; Huang G; Ying S; Du X; Chen Q; Jin R; Wu J; Liang G
Tumour Biol; 2016 Apr; 37(4):4791-801. PubMed ID: 26520440
[TBL] [Abstract][Full Text] [Related]
35. p120-catenin participates in the progress of gastric cancer through regulating the Rac1 and Pak1 signaling pathway.
Li TF; Qin SH; Ruan XZ; Wang X
Oncol Rep; 2015 Nov; 34(5):2357-64. PubMed ID: 26324182
[TBL] [Abstract][Full Text] [Related]
36. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.
Liu W; Lu Y; Chai X; Liu X; Zhu T; Wu X; Fang Y; Liu X; Zhang X
J Exp Clin Cancer Res; 2016 Nov; 35(1):183. PubMed ID: 27887633
[TBL] [Abstract][Full Text] [Related]
38. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
[TBL] [Abstract][Full Text] [Related]
39. P21-activated protein kinase 1 induces colorectal cancer metastasis involving ERK activation and phosphorylation of FAK at Ser-910.
Li LH; Zheng MH; Luo Q; Ye Q; Feng B; Lu AG; Wang ML; Chen XH; Su LP; Liu BY
Int J Oncol; 2010 Oct; 37(4):951-62. PubMed ID: 20811717
[TBL] [Abstract][Full Text] [Related]
40. Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer.
El-Baba C; Mahadevan V; Fahlbusch FB; Mohan S S; Rau TT; Gali-Muhtasib H; Schneider-Stock R
Mol Cancer; 2014 Aug; 13():201. PubMed ID: 25174975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
